The 2022 legislative session, the Second Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that began with the legislature having significant financial resources to accelerate the state’s economic recovery from the COVID-19 pandemic. One benefit of these additional financial resources was the expansion of the Advanced Industries Investment Tax Credit. A significant priority for CBSA was securing the passage of HB22-1149, which reauthorized the tax credit for four years and increased the funds available by 433% to $4 million annually. The program is critical to our life sciences community because it generates new investment in growth companies working to save and change lives around the world. CBSA supports access to capital at all stages of commercialization through our Capital + Growth efforts.
Another bill that CBSA supported this year was SB22-186, which creates the Colorado Rare Disease Advisory Council in… Click here to view original post
